Fluorescent RT in situ PCR detection of MRP1 mRNA in human HCV infected liver

Submitted: 24 December 2009
Accepted: 24 December 2009
Published: 24 December 2009
Abstract Views: 489
PDF: 426
Publisher's note
All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article or claim that may be made by its manufacturer is not guaranteed or endorsed by the publisher.

Authors

Chronic hepatitis C is now a major cause of chronic liver disease, cirrhosis and hepatocellular carcinoma. Approximately 20% of cases of acute viral hepatitis are due to hepatitis C. Cirrhosis develops in more than 25% of patients with chronic infection and each year hepatocellular carcinoma occurs in 1-3% of patients with cirrhosis due to HCV (Hoofnagle 1999). Patients with hepatocellular carcinoma are characterized by nonresponsiveness to chemotherapeutic agents. A cause of refractivity to treatment has been ascribed to the overexpression of the Pgp (MDR) protein (Kim et al. 1999), and the additional involvement of multidrug resistance-associated proteins (MRPs) has been also hypothesized (Minemura et al. 1999).

Dimensions

Altmetric

PlumX Metrics

Downloads

Download data is not yet available.

Citations

How to Cite

Pascolo, L., Bogoni, S., Spanò, A., Demori, E., Amoroso, A., & Crovella, S. (2009). Fluorescent RT in situ PCR detection of MRP1 mRNA in human HCV infected liver. European Journal of Histochemistry, 45(1), 105–8. https://doi.org/10.4081/ejh.2001.1620